RxDoctor Payments Data

Ansuya Balroop

Physician Assistant · Miami, FLNPI 1386941383

Payments from drug & device makers

$3,672in general payments, 2019–2025

Across 153 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$1K
  • AstraZeneca$268
  • Coloplast$257
  • Boston Scientific$253
  • Blue Earth Diagnostics$243
  • Dendreon Pharmaceuticals LLC$158
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$3,44294%
  • Education$2306%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,672 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron88$79,441
GemtesaVibegron36$29,891
Methenamine Hippurate69$5,098
Tamsulosin Hcl197$3,197
Estradiol38$2,626
Finasteride105$2,017
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst98$1,502
Solifenacin Succinate19$1,107
Dutasteride33$1,095
Cefdinir69$1,026
CefuroximeCefuroxime Axetil63$650
Alfuzosin Hcl ErAlfuzosin Hcl33$646
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav83$588
Ciprofloxacin Hcl80$397
NitrofurantoinNitrofurantoin Macrocrystal15$262

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$1,058$79,44188 claims
Sumitomo Pharma America, Inc.Gemtesa$24$29,89136 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →